TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis


Por: van der Zee, J, Gijselinck, I, Van Mossevelde, S, Perrone, F, Dillen, L, Heeman, B, Baumer, V, Engelborghs, S, De Bleecker, J, Baets, J, Gelpi, E, Rojas-Garcia, R, Clarimon, J, Lleo, A, Diehl-Schmid, J, Alexopoulos, P, Perneczky, R, Synofzik, M, Just, J, Schols, L, Graff, C, Thonberg, H, Borroni, B, Padovani, A, Jordanova, A, Sarafov, S, Tournev, I, de Mendonca, A, Miltenberger-Miltenyi, G, Simoes do Couto, F, Ramirez, A, Jessen, F, Heneka, MT, Gomez-Tortosa, E, Danek, A, Cras, P, Vandenberghe, R, De Jonghe, P, De Deyn, PP, Sleegers, K, Cruts, M, Van Broeckhoven, C

Publicada: 1 mar 2017
Resumen:
We investigated the mutation spectrum of the TANK-Binding Kinase 1 (TBK1) gene and its associated phenotypic spectrum by exonic resequencing of TBK1 in a cohort of 2,538 patients with frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), or FTD plus ALS, ascertained within the European Early-Onset Dementia Consortium. We assessed pathogenicity of predicted protein-truncating mutations by measuring loss of RNA expression. Functional effect of in-frame amino acid deletions and missense mutations was further explored in vivo on protein level and in vitro by an NFB-induced luciferase reporter assay and measuring phosphorylated TBK1. The protein-truncating mutations led to the loss of transcript through nonsense-mediated mRNA decay. For the in-frame amino acid deletions, we demonstrated loss of TBK1 or phosphorylated TBK1 protein. An important fraction of the missense mutations compromised NFB activation indicating that at least some functions of TBK1 are lost. Although missense mutations were also present in controls, over three times more mutations affecting TBK1 functioning were found in the mutation fraction observed in patients only, suggesting high-risk alleles (P = 0.03). Total mutation frequency for confirmed TBK1 LoF mutations in the European cohort was 0.7%, with frequencies in the clinical subgroups of 0.4% in FTD, 1.3% in ALS, and 3.6% in FTD-ALS.

Filiaciones:
van der Zee, J:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

Gijselinck, I:
 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

Van Mossevelde, S:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

 Univ Antwerp Hosp, Dept Neurol, Edegem, Belgium

Perrone, F:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

Dillen, L:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

Heeman, B:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

Baumer, V:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

Engelborghs, S:
 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

 Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Dept Neurol, Antwerp, Belgium

 Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Memory Clin, Antwerp, Belgium

De Bleecker, J:
 Univ Hosp Ghent, Dept Neurol, Ghent, Belgium

 Univ Ghent, Ghent, Belgium

Baets, J:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

 Univ Antwerp Hosp, Dept Neurol, Edegem, Belgium

Gelpi, E:
 Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Neurol Tissue Bank Biobanc, Barcelona, Spain

Rojas-Garcia, R:
 Univ Autonoma Barcelona, Hosp Santa Creu & Sant Pau, Dept Neurol, IIB Sant Pau, Barcelona, Spain

Clarimon, J:
 Univ Autonoma Barcelona, Hosp Santa Creu & Sant Pau, Dept Neurol, IIB Sant Pau, Barcelona, Spain

 Ctr Networker Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain

Lleo, A:
 Ctr Networker Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain

Diehl-Schmid, J:
 Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany

Alexopoulos, P:
 Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany

Perneczky, R:
 Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany

 Imperial Coll Sci Technol & Med, Sch Publ Hlth, Neuroepidemiol & Ageing Res Unit, London, England

 West London Cognit Disorders Treatment & Res Unit, West London Mental Hlth Trust, London TW8 8DS, England

Synofzik, M:
 Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany

 Ctr Neurol, Tubingen, Germany

 German Res Ctr Neurodegenerat Dis DZNE, Tubingen, Germany

Just, J:
 Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany

 Ctr Neurol, Tubingen, Germany

 German Res Ctr Neurodegenerat Dis DZNE, Tubingen, Germany

Schols, L:
 Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany

 Ctr Neurol, Tubingen, Germany

 German Res Ctr Neurodegenerat Dis DZNE, Tubingen, Germany

Graff, C:
 Karolinska Inst, KI Alzheimer Dis Res Ctr, Dept Neurobiol, Care Sci & Soc NVS, Stockholm, Sweden

 Karolinska Univ Hosp, Dept Geriatr Med, Genet Unit, Stockholm, Sweden

Thonberg, H:
 Karolinska Inst, KI Alzheimer Dis Res Ctr, Dept Neurobiol, Care Sci & Soc NVS, Stockholm, Sweden

 Karolinska Univ Hosp, Dept Geriatr Med, Genet Unit, Stockholm, Sweden

Borroni, B:
 Univ Brescia, Neurol Unit, Brescia, Italy

Padovani, A:
 Univ Brescia, Neurol Unit, Brescia, Italy

Jordanova, A:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

 Med Univ Sofia, Mol Med Ctr, Dept Biochem, Sofia, Bulgaria

Sarafov, S:
 Med Univ Sofia, Dept Neurol, Sofia, Bulgaria

Tournev, I:
 New Bulgarian Univ, Dept Cognit Sci & Psychol, Sofia, Bulgaria

de Mendonca, A:
 Hosp Santa Maria, Lisbon, Portugal

 Univ Lisbon, Fac Med, Lisbon, Portugal

 Univ Lisbon, Inst Mol Med, Lisbon, Portugal

Miltenberger-Miltenyi, G:
 Hosp Santa Maria, Lisbon, Portugal

 Univ Lisbon, Fac Med, Lisbon, Portugal

 Univ Lisbon, Inst Mol Med, Lisbon, Portugal

Simoes do Couto, F:
 Hosp Santa Maria, Lisbon, Portugal

 Univ Lisbon, Fac Med, Lisbon, Portugal

 Univ Lisbon, Inst Mol Med, Lisbon, Portugal

Ramirez, A:
 Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany

 Univ Bonn, Inst Human Genet, Bonn, Germany

 Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany

Jessen, F:
 Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany

 Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany

 German Ctr Neurodegenerat Dis DZNE, Bonn, Germany

Heneka, MT:
 German Ctr Neurodegenerat Dis DZNE, Bonn, Germany

 Univ Bonn, Dept Neurol, Clin Neurosci Unit, Bonn, Germany

Gomez-Tortosa, E:
 Dept Neurol, Fundac Jimenez Diaz, Madrid, Spain

Danek, A:
 Ludwig Maximilians Univ Munchen, Dept Neurol, Munich, Germany

 German Ctr Neurodegenerat Dis DZNE, Munich, Germany

Cras, P:
 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

 Univ Antwerp Hosp, Dept Neurol, Edegem, Belgium

Vandenberghe, R:
 Katholieke Univ Leuven, Fac Med, Dept Neurosci, Leuven, Belgium

 Univ Hosp Leuven, Dept Neurol, Leuven, Belgium

De Jonghe, P:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

 Univ Antwerp Hosp, Dept Neurol, Edegem, Belgium

De Deyn, PP:
 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

 Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Dept Neurol, Antwerp, Belgium

 Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Memory Clin, Antwerp, Belgium

Sleegers, K:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

Cruts, M:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

Van Broeckhoven, C:
 VIB, Ctr Mol Neurol, Antwerp, Belgium

 Univ Antwerp, Inst Born Bunge, Antwerp, Belgium
ISSN: 10597794
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Estados Unidos America
Tipo de documento: Article
Volumen: 38 Número: 3
Páginas: 297-309
WOS Id: 000394905800010
ID de PubMed: 28008748
imagen Green Published, Hybrid Gold

MÉTRICAS